49 related articles for article (PubMed ID: 25615851)
1. Mutational profiling of second primary lung cancers in patients who have received radiation for the treatment of Hodgkin's disease.
Bond DA; Dunavin N; Otterson GA
Cancer Invest; 2015 Mar; 33(3):86-8. PubMed ID: 25615851
[TBL] [Abstract][Full Text] [Related]
2. Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease.
Behrens C; Travis LB; Wistuba II; Davis S; Maitra A; Clarke EA; Lynch CF; Glimelius B; Wiklund T; Tarone R; Gazdar AF
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1027-35. PubMed ID: 11045784
[TBL] [Abstract][Full Text] [Related]
3. p53 mutations in lung cancer following radiation therapy for Hodgkin's disease.
De Benedetti VM; Travis LB; Welsh JA; van Leeuwen FE; Stovall M; Clarke EA; Boice JD; Bennett WP
Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):93-8. PubMed ID: 8850268
[TBL] [Abstract][Full Text] [Related]
4. TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms.
Nichols KE; Heath JA; Friedman D; Biegel JA; Ganguly A; Mauch P; Diller L
J Clin Oncol; 2003 Dec; 21(24):4505-9. PubMed ID: 14673037
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease.
Nichols KE; Levitz S; Shannon KE; Wahrer DC; Bell DW; Chang G; Hegde S; Neuberg D; Shafman T; Tarbell NJ; Mauch P; Ishioka C; Haber DA; Diller L
J Clin Oncol; 1999 Apr; 17(4):1259. PubMed ID: 10561187
[TBL] [Abstract][Full Text] [Related]
6. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
[TBL] [Abstract][Full Text] [Related]
7. Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications.
Wu CC; Hsu HY; Liu HP; Chang JW; Chen YT; Hsieh WY; Hsieh JJ; Hsieh MS; Chen YR; Huang SF
Cancer; 2008 Dec; 113(11):3199-208. PubMed ID: 18932251
[TBL] [Abstract][Full Text] [Related]
8. The clinical course of nonsmall cell lung carcinoma in survivors of Hodgkin disease.
Laurie SA; Kris MG; Portlock CS; Rosenzweig KE; Miller VA; Krug LM; Rusch VW
Cancer; 2002 Jul; 95(1):119-26. PubMed ID: 12115325
[TBL] [Abstract][Full Text] [Related]
9. EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.
Schmid K; Oehl N; Wrba F; Pirker R; Pirker C; Filipits M
Clin Cancer Res; 2009 Jul; 15(14):4554-60. PubMed ID: 19584155
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of small cell lung cancer in a Japanese cohort.
Wakuda K; Kenmotsu H; Serizawa M; Koh Y; Isaka M; Takahashi S; Ono A; Taira T; Naito T; Murakami H; Mori K; Endo M; Nakajima T; Ohde Y; Takahashi T; Yamamoto N
Lung Cancer; 2014 May; 84(2):139-44. PubMed ID: 24657128
[TBL] [Abstract][Full Text] [Related]
11. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
[TBL] [Abstract][Full Text] [Related]
12. Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.
M'kacher R; Bennaceur-Griscelli A; Girinsky T; Koscielny S; Delhommeau F; Dossou J; Violot D; Leclercq E; Courtier MH; Béron-Gaillard N; Assaf E; Ribrag V; Bourhis J; Feneux D; Bernheim A; Parmentier C; Carde P
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):465-71. PubMed ID: 17418962
[TBL] [Abstract][Full Text] [Related]
13. Differential genetic and functional markers of second neoplasias in Hodgkin's disease patients.
Lorenzo Y; Provencio M; Lombardía L; Díaz R; Silva J; Herrera M; García JM; Peña C; García V; Romero J; Domínguez G; Bonilla F
Clin Cancer Res; 2009 Aug; 15(15):4823-8. PubMed ID: 19622580
[TBL] [Abstract][Full Text] [Related]
14. Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.
Offit K; Gilad S; Paglin S; Kolachana P; Roisman LC; Nafa K; Yeugelewitz V; Gonzales M; Robson M; McDermott D; Pierce HH; Kauff ND; Einat P; Jhanwar S; Satagopan JM; Oddoux C; Ellis N; Skaliter R; Yahalom J
Clin Cancer Res; 2002 Dec; 8(12):3813-9. PubMed ID: 12473594
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer.
Tomizawa Y; Iijima H; Sunaga N; Sato K; Takise A; Otani Y; Tanaka S; Suga T; Saito R; Ishizuka T; Dobashi K; Minna JD; Nakajima T; Mori M
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6816-22. PubMed ID: 16203769
[TBL] [Abstract][Full Text] [Related]
16. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
Tam IY; Chung LP; Suen WS; Wang E; Wong MC; Ho KK; Lam WK; Chiu SW; Girard L; Minna JD; Gazdar AF; Wong MP
Clin Cancer Res; 2006 Mar; 12(5):1647-53. PubMed ID: 16533793
[TBL] [Abstract][Full Text] [Related]
17. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.
Okayama H; Kohno T; Ishii Y; Shimada Y; Shiraishi K; Iwakawa R; Furuta K; Tsuta K; Shibata T; Yamamoto S; Watanabe S; Sakamoto H; Kumamoto K; Takenoshita S; Gotoh N; Mizuno H; Sarai A; Kawano S; Yamaguchi R; Miyano S; Yokota J
Cancer Res; 2012 Jan; 72(1):100-11. PubMed ID: 22080568
[TBL] [Abstract][Full Text] [Related]
18. New aspects of the clinicopathology and genetic profile of metachronous multiple lung cancers.
Wu CT; Lin MW; Hsieh MS; Kuo SW; Chang YL
Ann Surg; 2014 May; 259(5):1018-24. PubMed ID: 24368645
[TBL] [Abstract][Full Text] [Related]
19. Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung.
Kim YT; Kim TY; Lee DS; Park SJ; Park JY; Seo SJ; Choi HS; Kang HJ; Hahn S; Kang CH; Sung SW; Kim JH
Lung Cancer; 2008 Jan; 59(1):111-8. PubMed ID: 17904685
[TBL] [Abstract][Full Text] [Related]
20. Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease.
Strom SS; Gu Y; Sigurdson AJ; Bailey NM; Amos CI; Spitz MR; Rodriguez MA; Liang JC
Leuk Lymphoma; 1998 Feb; 28(5-6):561-6. PubMed ID: 9613986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
